Evergreen International Phage Biology Meeting 2019 JAFRAL is going to be [...]
JAFRAL is proud to be a GMP manufacturing partner of a consortium/project for first clinical trial on combined electrochemotherapy with gene therapy with Interleukin-12 (IL-12) to improve/enhance local and systemic response to skin tumor treatment.
On 20th September 2017, WHO launched report about antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis. Report shows a
Because there have not been rigorous clinical trials of phages, they can be used only on patients for whom all other options have failed.